title: The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo.
authors.forename: Christian
authors.initials: C
authors.lastname: Hafner
authors.forename: Robert
authors.initials: R
authors.lastname: Stoehr
authors.forename: Johanna M M
authors.initials: JM
authors.lastname: van Oers
authors.forename: Ellen C
authors.initials: EC
authors.lastname: Zwarthoff
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Hofstaedter
authors.forename: Christoph
authors.initials: C
authors.lastname: Klein
authors.forename: Michael
authors.initials: M
authors.lastname: Landthaler
authors.forename: Arndt
authors.initials: A
authors.lastname: Hartmann
authors.forename: Thomas
authors.initials: T
authors.lastname: Vogt
mesh_terms: D058534:Class I Phosphatidylinositol 3-Kinases; D003937:Diagnosis, Differential; D005820:Genetic Testing; D006801:Humans; D007911:Lentigo / Q000235:genetics*; D009154:Mutation; D009508:Nevus, Pigmented / Q000235:genetics*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*
chemical_list: D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human; C496365:FGFR3 protein, human; D051498:Receptor, Fibroblast Growth Factor, Type 3; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf